Standard regimens add either oral micronized progesterone, a combined patch, or a progestin-releasing IUD
Tirzepatide set a precedence in demonstrating the clinical efficacy of dual agonism in type 2 diabetes patients, but there is still much to learn about how these therapies perform in type 1 diabetes, and how they affect weight, glycemic control, insulin doses, and overall metabolism when used as an adjunct to insulin
Caution: Consult your healthcare professional prior to use
Based on its ability to protect cells, it plays a unique role in reproductive health, supporting both male and female fertility
31 Clinically, GLP-1 RA use in patients with diabetes is associated with significant primary risk reduction of several obesity-associated cancers
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study